Panenza swine influenza A: Final Phase II data

Final data from a placebo-controlled, U.S. Phase II trial in 474 healthy children showed that a second 7.5 µg dose of Sanofi Pasteur S.A.'s intramuscular swine influenza A (H1N1) vaccine produced ser...